Home  |  Contact

Cellosaurus SBC-3/CDDP (CVCL_M842)

[Text version]
Cell line name SBC-3/CDDP
Accession CVCL_M842
Resource Identification Initiative To cite this cell line use: SBC-3/CDDP (RRID:CVCL_M842)
Comments Population: Japanese.
Doubling time: 27.5 hours (PubMed=9615743; PubMed=10628341).
Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
Disease Lung small cell carcinoma (NCIt: C4917)
Small cell lung cancer (ORDO: Orphanet_70573)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1678 (SBC-3)
Sex of cell Male
Age at sampling 24Y
Category Cancer cell line
Publications

PubMed=9227790; DOI=10.18926/AMO/30795
Matsuo K., Kiura K., Ueoka H., Tabata M., Shibayama T., Matsumura T., Takigawa N., Hiraki S., Harada M.
Growth inhibitory effects of antifolates against an adriamycin-resistant human small cell lung cancer cell line.
Acta Med. Okayama 51:121-127(1997)

PubMed=9615743
Moritaka T., Kiura K., Ueoka H., Tabata M., Segawa Y., Shibayama T., Takigawa N., Ohnoshi T., Harada M.
Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
Anticancer Res. 18:927-933(1998)

PubMed=10628341
Ikubo S., Takigawa N., Ueoka H., Kiura K., Tabata M., Shibayama T., Chikamori M., Aoe K., Matsushita A., Harada M.
In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines.
Anticancer Res. 19:3985-3988(1999)

Cross-references
Encyclopedic resources Wikidata; Q54952171
Entry history
Entry creation05-Nov-2013
Last entry update29-Jun-2023
Version number13